| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 03/21/1995 | US5399338 Enhancement of abnormal tissue uptake of antibodies, tumor-specific agents or conjugates thereof for diagnostic imaging or therapy |
| 03/16/1995 | WO1995007467A1 Assay systems using the cntf signal transduction pathway |
| 03/16/1995 | WO1995007270A1 Chelants as contrast enhancing agents |
| 03/16/1995 | WO1995007098A1 Methods for regulating gastrointestinal motility |
| 03/16/1995 | WO1995007072A2 Active principles and gas containing microparticles |
| 03/16/1995 | WO1995007049A1 Diagnostic uses of hydrazinoadenosines |
| 03/16/1995 | DE4330958A1 Novel microparticles containing active compound, media containing these, their use for the ultrasonically controlled release of active compounds and process for the production thereof |
| 03/15/1995 | EP0642761A1 Method of quantitative determination of bone salt with ct equipment |
| 03/15/1995 | EP0642591A1 Therapy and diagnosis of conditions related to telomere length and/or telomerase activity |
| 03/15/1995 | EP0642582A1 Hybrid siv/hiv-1 viral vectors and monkey model for aids |
| 03/15/1995 | EP0642492A1 5,5'-/(1,3-propanediyl) bis-/imino(2-oxo-2,1-ethanediyl)acetylimino/bis(2,4,6-triiodo-1,3-benzenedicarboxyamides), and contrast media containing them. |
| 03/15/1995 | EP0642353A1 Treatment of vascular leakage syndrome and collagenase induced disease by administration of matrix metalloproteinase inhibitors |
| 03/14/1995 | US5397777 Introducing solubility balanced composition into circulatory system of mammal organism and making an image |
| 03/14/1995 | US5397563 Perfluoro-t-butyl-containing steroids for use in fluorine-19 NMR and/or MRI |
| 03/14/1995 | US5397562 Administering fluorocarbon emulsions, determination of oxygen tension, diagnosis of tumors based on degree of hypoxia |
| 03/09/1995 | WO1995006518A1 Polymeric surfactant-encapsulated microbubbles and their use in ultrasound imaging |
| 03/09/1995 | WO1995006483A1 A method and pharmaceutical and diagnosis compositions for drug targeting |
| 03/09/1995 | WO1995006480A1 Methods of prolonged suppression of humoral immunity |
| 03/09/1995 | CA2170906A1 Polymeric surfactant-encapsulated microbubbles and their use in ultrasound imaging |
| 03/08/1995 | EP0641796A1 Wavelength-specific cytotoxic agents |
| 03/08/1995 | EP0429539B1 Magnetic resonance imaging with perfluorocarbon hydrides |
| 03/08/1995 | CN1099613A Method and medical agent for diagnosis and/or therapy of arthritis |
| 03/02/1995 | WO1995006058A1 Polymer modification |
| 03/02/1995 | WO1995006053A1 Tris(substituted phenyl)bismuth derivative |
| 03/02/1995 | WO1995005854A1 Contrasting agents for ultrasonic diagnosis |
| 03/02/1995 | WO1995005847A1 Accessory factor function for interferon gamma and its receptor |
| 03/02/1995 | WO1995005818A1 Photosensitizers |
| 03/02/1995 | WO1995005810A1 Compositions and methods for the detection and treatment of protein trafficking disorders and increasing secretory protein production |
| 03/02/1995 | DE4328639A1 Method for measuring the antioxidant potential of the skin |
| 03/02/1995 | CA2170155A1 Tris(substituted phenyl)bismuth derivatives |
| 03/02/1995 | CA2169849A1 Accessory factor function for interferon gamma and its receptor |
| 03/02/1995 | CA2169210A1 Compositions and methods for the detection and treatment of protein trafficking disorders and increasing secretory protein production |
| 03/01/1995 | EP0640350A2 Ceramic particles and their preparation |
| 03/01/1995 | EP0640211A1 Method of preparing a diagnostic agent for detecting inflammations |
| 03/01/1995 | EP0640067A1 Improved synthesis of ioversol. |
| 02/28/1995 | US5393891 Useful as standards in testing for presence of quinoline carboxylic acids |
| 02/28/1995 | US5393530 Method for making liposomes of enhanced entrapping capacity toward foreign substances to be encapsulated |
| 02/28/1995 | US5393525 Contrast medium comprising superparamagnetic or ferromagnetic particles capable of increasing viscosity after administration |
| 02/28/1995 | US5393524 Using microbubbles of biocompatible fluorocarbon containing contrast-enhancing chemical |
| 02/23/1995 | WO1995005669A1 Synthesis of polysaccharide covered superparamagnetic oxide colloids |
| 02/23/1995 | WO1995005397A1 Composition and methods using nitroxides to avoid oxygen toxicity |
| 02/23/1995 | WO1995005394A1 Therapeutic and diagnostic agents for amyloidosis |
| 02/23/1995 | WO1995005202A1 Iodinated borane cage molecules as x-ray contrast media |
| 02/23/1995 | WO1995005118A1 Polyamino paramagnetic chelates which contain both phosphonate and non-phosphonate moieties for mri |
| 02/23/1995 | DE4328331A1 Continuous high-pressure extrusion process for the production of liposomes and emulsions |
| 02/23/1995 | CA2169178A1 Composition and methods using nitroxides to avoid oxygen toxicity |
| 02/22/1995 | EP0639270A1 Phosphorylated contrast agents for mri of the gi tract |
| 02/22/1995 | EP0639083A1 Complexing agents and targeting immunoreagents |
| 02/22/1995 | CN1098943A Chinese medicinal developing liquid for gastric B ultrasonic examination |
| 02/21/1995 | US5391876 Hole-trap-compensated scintillator material and computed tomography machine containing the same |
| 02/21/1995 | US5391696 Polycondensates which contain tartaric acid derivatives, processes for their preparation and use thereof |
| 02/21/1995 | US5391547 Method using 5,10,15,20-tetrakis(4-carboxyphenyl)porphine for treating cancers of the lung |
| 02/21/1995 | US5391376 Method for preventing and treating cachexia |
| 02/21/1995 | CA1334513C Covalently-linked complexes and methods for enhanced cytotoxicity and imaging |
| 02/16/1995 | WO1995004753A1 Compositions of fusion proteins containing metallothionein and targeting-protein structural components |
| 02/16/1995 | WO1995004499A1 Organic silicon contrast agents for magnetic resonance imaging |
| 02/15/1995 | EP0638619A2 Magnetic ink concentrate |
| 02/15/1995 | EP0638618A2 Magnetic ink concentrate |
| 02/15/1995 | EP0638318A2 Compositions for increasing the image contrast in diagnostic investigations of the digestive tract |
| 02/15/1995 | EP0637967A1 Improved method |
| 02/15/1995 | EP0637933A1 Method and kit for imaging and treating organs and tissues |
| 02/14/1995 | US5389520 Specific detection of cell surface receptor leukocyte adhesion molecule-1 |
| 02/14/1995 | US5389377 Solid care therapeutic compositions and methods for making same |
| 02/09/1995 | WO1995004031A1 Process for the crystallization of iopamidol |
| 02/09/1995 | WO1995003835A1 Stabilized microbubble compositions for ultrasound |
| 02/09/1995 | DE4325949A1 Device for opacifying the human appendix |
| 02/08/1995 | EP0637333A1 Ifn receptors recognition factors, protein sequences and methods of use thereof |
| 02/08/1995 | EP0637310A1 Water-soluble retinoids |
| 02/08/1995 | EP0637252A1 Nhr contrast agents |
| 02/08/1995 | EP0637246A1 Methods of treating cancer using modified c-reactive protein |
| 02/08/1995 | CN1027575C Ultrasonic contrast medium made up of small gas bubbles and fatty-acid-contg. microparticles |
| 02/07/1995 | US5387504 Monospecific antibodies and assay system for detecting stromelysin cleavage products |
| 02/07/1995 | US5387410 Administering nontoxic paramagnetic image altering chelate compound |
| 02/07/1995 | CA1334281C Emulsion for parenteral administration |
| 02/02/1995 | WO1995003422A1 Method for diagnosing a disorder by determining expression of gage tumor rejection antigen precursors |
| 02/02/1995 | WO1995003357A1 Biodegradable particles |
| 02/02/1995 | WO1995003356A1 Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers |
| 02/02/1995 | WO1994029316A3 Texaphyrin metal complex mediated ester hydrolysis |
| 02/02/1995 | WO1994028780A3 Methods of preparing gas and gaseous precursor-filled microspheres |
| 02/02/1995 | DE4325100A1 Highly fluorinated alkanes and medicinal applications |
| 02/02/1995 | CA2167920A1 Nonoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers |
| 02/01/1995 | EP0636246A1 Method and kit for epithelial cancer screening |
| 02/01/1995 | EP0636032A1 Method of intraoperatively detecting and locating tumoral tissues |
| 01/31/1995 | US5385893 Tricyclopolyazamacrocyclophosphonic acids, complexes and derivatives thereof, for use as contrast agents |
| 01/31/1995 | US5385822 Methods for detection and quantification of cell subsets within subpopulations of a mixed cell population |
| 01/31/1995 | US5385725 Echo contrast agent for left heart opacification and method of using the same |
| 01/31/1995 | US5385724 Trifluoromethyl analogs of X-ray contrast media for magnetic resonance imaging |
| 01/31/1995 | US5385723 Quantitate the inflammatory response to viscoelastic agents or solutions |
| 01/31/1995 | US5385722 Compositions of iodophenyl esters and iodophenyl sulfonates and cellulose derivatives for visualization of the gastrointestinal tract |
| 01/31/1995 | US5385721 X-ray radiology and computer tomography; uniform coating of the soft tissues; medical diagnosis |
| 01/31/1995 | US5385720 X-ray radiology and computer tomography; uniform coating of the soft tissues; medical diagnosis |
| 01/31/1995 | US5385719 Paramagnetic ion chelated to polymers; x-ray and ultrasonic contrast agents, nuclear medicine imaging, radiotherapy, |
| 01/31/1995 | US5385147 Method of ultrasonic imaging of the gastrointestinal tract and upper abdominal organs using an orally administered negative contrast medium |
| 01/26/1995 | WO1995002831A1 Methods and compositions for image contrast enhancing |
| 01/26/1995 | WO1995002701A1 Method of identifying human and animal cells capable of unlimited proliferation or tumour formation |
| 01/26/1995 | WO1995002424A1 Localization and therapy of non-prostatic endocrine cancer with agents directed against prostate specific antigen |
| 01/26/1995 | WO1994028781A3 Magnetic resonance arteriography with dynamic intravenous contrast agents |
| 01/26/1995 | CA2166976A1 Method for identifying human and animal cells having an unlimited proliferation or tumor-formation potential |
| 01/26/1995 | CA2165086A1 Methods and compositions for image contrast enhancing |
| 01/25/1995 | EP0635029A1 Cartilage matrix protein and methods for use |